(Q38237908)

31 August 2017

title

Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences (English)

1 reference

31 August 2017

1

1 reference

31 August 2017

Nikolas H Stoecklein

2

1 reference

31 August 2017

publication date

8 August 2014

1 reference

Cellular and Molecular Life Sciences

31 August 2017

published in

1 reference

31 August 2017

volume

71

1 reference

31 August 2017

issue

22

1 reference

31 August 2017

page(s)

4393-4402

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-014-1693-1

31 August 2017

exact match

0 references

cites work

Parallel progression of primary tumours and metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Detection of cancer before distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumor cells: a multifunctional biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumour cells in cancer patients: challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Challenges in the enumeration and phenotyping of CTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Detection of circulating cancer cells in lung cancer patients with a panel of marker genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Frequent EpCam protein expression in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The biology of the 17-1A antigen (Ep-CAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM and its potential role in tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM is involved in maintenance of the murine embryonic stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumour cells in non-metastatic breast cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The epigenetics of epithelial-mesenchymal plasticity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The emerging role of EpCAM in cancer and stem cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM: another surface-to-nucleus missile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Nuclear signalling by tumour-associated antigen EpCAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Regulated intramembrane proteolysis and degradation of murine epithelial cell adhesion molecule mEpCAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EPCAM deletions, Lynch syndrome, and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

History, genetics, and strategies for cancer prevention in Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM controls actomyosin contractility and cell adhesion by direct inhibition of PKC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM regulates cell cycle progression via control of cyclin D1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM is an endoderm-specific Wnt derepressor that licenses hepatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM expression in the prostate cancer makes the difference in the response to growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Filtration parameters influencing circulating tumor cell enrichment from whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Portable filter-based microdevice for detection and characterization of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1693-1

Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells

21 January 2018

1 reference

12 December 2020

Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development

1 reference

12 December 2020

In vivo and in vitro labelling of epithelial tumor cells with anti 17-1A monoclonal antibodies in bone marrow of cancer patients

1 reference

12 December 2020

Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative

1 reference

12 December 2020

Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors

1 reference

12 December 2020

Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.

1 reference

12 December 2020

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.

1 reference

12 December 2020

The identification and characterization of breast cancer CTCs competent for brain metastasis

1 reference

12 December 2020

A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

1 reference

12 December 2020

Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer

1 reference

12 December 2020

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Context-dependent adaption of EpCAM expression in early systemic esophageal cancer

1 reference

12 December 2020

Flow cytometry--principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral blood

1 reference

12 December 2020

Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue

1 reference

12 December 2020

Tumor dissemination: an EMT affair

1 reference

12 December 2020

Loss of membranous Ep-CAM in budding colorectal carcinoma cells

1 reference

12 December 2020

10.1007/S00018-014-1693-1

Identifiers

DOI

1 reference

release_p4n62q7sivckllnjfafazptlwa

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p4n62q7sivckllnjfafazptlwa

24 November 2022

mapped directly with Wikidata item

1 reference